Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Is Azacitidine (AZA) Really Effective in High Risk MDS Patients with Chromosome 7 Abnormalities (Abn 7)? Results of a Retrospective Study From the GFM and GESMD Registries

Blood (2012) 120 (21): 1713.

https://doi.org/10.1182/blood.V120.21.1713.1713

Published: 2012

Journal Articles

Age, Performance Status and Plasma Interleukin-10 Levels At Diagnosis: A Triad for Improving Survival Prediction of Patients with Myelodysplastic Syndromes Already Stratified by IPSS-R. Spanish MDS Group (GESMD)

Fernando Ramos, MD, PhD, MPH, Carmen Pedro, Jose-Maria Garcia-Ruiz-de-Morales, Eva Barragan, Raquel de Paz, Andres Insunza, Mar Tormo, Maria Diez-Campelo, Blanca Xicoy, Eduardo Salido, Javier Sanchez-del-Real, Leonor Arenillas, Carlos Santamaria, Noemi Puig, Lourdes Florensa, Francesc Sole, Marcos González, Elisa Luño, Guillermo F Sanz

Blood (2012) 120 (21): 3803.

https://doi.org/10.1182/blood.V120.21.3803.3803

Published: 2012

Journal Articles

Identification of Poor Risk Patients in Low and Intermediate-1 (Int-1) IPSS MDS with the New Ipssr Index and Comparison with Other Prognostic Indexes. A Study by the Spanish Group of MDS (GESMD)

Blood (2012) 120 (21): 702.

https://doi.org/10.1182/blood.V120.21.702.702

Published: 2012

Journal Articles

Prognostic Impact of Monosomal Karyotype in Patients with Myelodysplastic Syndrome and Abnormal Karyotype. A Report From the Spanish Group of MDS (GESMD)

David Valcárcel, MD, Vera Adema, Mar Mallo, Margarita Ortega, PhD, Benet Nomdedeu, MD, Guillermo Sanz, MD, Elisa Luño, MD, Del CaÃ‘izo Consuelo, MD, PhD, Javier De la Serna, MD, PhD, Maita Ardanaz, MD, Victor Marco, MD, Rosa Collado, Blanca Xicoy, MD, Francesc Sole, PhD, Teresa Vallespi, MD, PhD

Blood (2011) 118 (21): 1724.

https://doi.org/10.1182/blood.V118.21.1724.1724

Published: 2011

Journal Articles

Loss of the Y Chromosome in MDS - Age-Related Phenomenon or Clonal Abnormality?

Blood (2010) 116 (21): 4008.

https://doi.org/10.1182/blood.V116.21.4008.4008

Published: 2010

Journal Articles

Efficacy and Effectiveness of Azacitidine In Elderly Patients with Acute Myeloid Leukemia and Blasts Counts below 30%: Experience of the Spanish Registry

Regina García, Monserrat Arnar, Elisa Luño, Joan Bargay, Ma Mar Romero, Juan Besalduch, Elena Amutio, Raquel Garrido, Fernando Carnicero, Grupo Andaluz de Smd

Blood (2010) 116 (21): 4354.

https://doi.org/10.1182/blood.V116.21.4354.4354

Published: 2010

Journal Articles

Analysis of Spanish Experience During Imiglucerase Shortage

Pilar Giraldo, PhD, Pilar Irún, PhD, Pilar Alfonso, PhD, Jaime Dalmau, MD, MAngeles Fernández-Galán, MD, Antonio Figueredo, MD, Angela Ibañez, MD, Jesús M Hernández-Rivas, PhD, Elisa Luño, MD, Francisca Marín-Jimenez, Guillermo Martin-Nuñez, MD, Jorge Montserrat, MD, Javier De la Serna, MD, PhD, Lucia Villalon, MD, Miguel Pocovi, PhD

Blood (2010) 116 (21): 4725.

https://doi.org/10.1182/blood.V116.21.4725.4725

Published: 2010

Journal Articles

A New Prognostic Scoring System Including Transfusion Dependency and Cytogenetic Abnormalities for Patients with Chronic Myelomonocytic Leukemia.

Blood (2009) 114 (22): 1750.

https://doi.org/10.1182/blood.V114.22.1750.1750

Published: 2009

Journal Articles

Chronic Myelomonocytic Leukemia (CMML) with More Than 15% of Ring Sideroblasts in Bone Marrow: An Overlapping Disorder Between CMML and Refractory Anemia with Ring Sideroblasts.

Blood (2009) 114 (22): 290.

https://doi.org/10.1182/blood.V114.22.290.290

Published: 2009

Journal Articles

Treatment of Anemia with Darbepoetin Alfa in Patients with Low and Intermediate-1 Risk Myelodysplastic Syndromes. Results from the ARAMYS Study

Ana Villegas, MD, PhD, B. Arrizabalaga, C. Fernández-lago, M. Mouzo, Jr Mayans, Jr Gonález-Porras, Rafael Duarte, MD, PhD, Angel Francisco Remacha, Elisa Luño, MD, PhD, JA Gasquet

Blood (2008) 112 (11): 3451.

https://doi.org/10.1182/blood.V112.11.3451.3451

Published: 2008

Journal Articles

Analysis of Cytogenetic Abnormalities and Their Prognostic Impact in a Series of 145 Mantle Cell Lymphoma Cases with An Abnormal Karyotype.

Blanca Espinet, PhD, Salaverría Itziar, PhD, Sílvia Beà, PhD, Neus Ruiz-Xivillé, Olga Balagué, MD, Marta Salido, Dolors Costa, PhD, Ana E Rodriguez, Juan LuíS. García, PhD, JesúS. M.ª Hernández-Rivas, MD, PhD, M.ª José Calasanz, PhD, Ana M Ferrer, MD, PhD, Antonio Salar, MD, PhD, Ana Carrió, PhD, Natividad Polo, Jose Antonio García-Marco, MD, PhD, Alicia Domingo, MD, Eva González-Barca, MD, PhD, Vicenç Romagosa, MD, Isabel Marugán, Armando López-Guillermo, MD, PhD, Fuensanta Millá, MD, José Luís Mate, MD, PhD, Elisa Luño, MD, PhD, Carmen Sanzo, MD, PhD, Rosa Collado, MD, PhD, Isabel Oliver, Sebastià Monzó, MD, Antonio Palacín, MD, Teresa González, Francesc Sant, MD, Ramon Salinas, MD, PhD, Mª Teresa Ardanaz, MD, Llorenç Font, MD, PhD, Lourdes Escoda, MD, Lourdes Florensa, MD, PhD, Elias Campo, MD, PhD, Sergi Serrano, MD, PhD, Francesc Solé, PhD

Blood (2008) 112 (11): 1765.

https://doi.org/10.1182/blood.V112.11.1765.1765

Published: 2008

Journal Articles

Prognostic Impact of Additional Chromosomal Aberrations (ACA) to 5q- in Patients with primary Myelodysplastic Syndrome.

Blood (2008) 112 (11): 1649.

https://doi.org/10.1182/blood.V112.11.1649.1649

Published: 2008

Journal Articles

Independent Impact of Iron Overload and Transfusion Dependency on Survival and Leukemic Evolution in Patients with Myelodysplastic Syndrome

Blood (2008) 112 (11): 640.

https://doi.org/10.1182/blood.V112.11.640.640

Published: 2008

Journal Articles

ABL1 Gene Amplification and Aberration Involving HOX11L2/TLX3 in T-Acute Lymphoblastic Leukemia (T-ALL).

Elisa Luño, Carmen Sanzo, Fermin Jonte, Regina LLorente, Emilia Fanjul, Soledad Gonzalez, Araceli Martínez

Blood (2006) 108 (11): 4443.

https://doi.org/10.1182/blood.V108.11.4443.4443

Published: 2006

Journal Articles

Elderly Patients with De Novo Acute Myeloid Leukemia (AML): Prognostic Factors in 132 Cases.

Elisa Luño, Carmen Sanzo, Fermin Jonte, Jose Maria Vicente, Dolores Carrera, Francesc Sole, Pablo Chamorro, Araceli Martinez

Blood (2006) 108 (11): 4454.

https://doi.org/10.1182/blood.V108.11.4454.4454

Published: 2006

Journal Articles

Acute Erythroid Leukemia (AEL): A Clinical, Morphological, Cytogenetic and Follow-Up Study of 69 Patients.

Elisa Luño, Carmen Sanzo, Francesc Sole, Mirian Gonzalez, Isabel Granada, Blanca Espinet, Cristina Chamorro, Rosa Collado, Ana Cabello, M. Jose Calasanz, Eva Arranz, Juan M. Bergua

Blood (2005) 106 (11): 3271.

https://doi.org/10.1182/blood.V106.11.3271.3271

Published: 2005

Journal Articles

Additional Chromosome Abnormalities Have No Prognostic Value in Acute Promyelocytic Leukemia Patients Treated with Simultaneous ATRA and Anthracycline-Based Chemotherapy: An Update of the APL96 and APL99 Pethema Protocols.

Blood (2004) 104 (11): 2019.

https://doi.org/10.1182/blood.V104.11.2019.2019

Published: 2004

NARROW

Is Azacitidine (AZA) Really Effective in High Risk MDS Patients with Chromosome 7 Abnormalities (Abn 7)? Results of a Retrospective Study From the GFM and GESMD Registries

Age, Performance Status and Plasma Interleukin-10 Levels At Diagnosis: A Triad for Improving Survival Prediction of Patients with Myelodysplastic Syndromes Already Stratified by IPSS-R. Spanish MDS Group (GESMD)

Identification of Poor Risk Patients in Low and Intermediate-1 (Int-1) IPSS MDS with the New Ipssr Index and Comparison with Other Prognostic Indexes. A Study by the Spanish Group of MDS (GESMD)

Prognostic Impact of Monosomal Karyotype in Patients with Myelodysplastic Syndrome and Abnormal Karyotype. A Report From the Spanish Group of MDS (GESMD)

Loss of the Y Chromosome in MDS - Age-Related Phenomenon or Clonal Abnormality?

Efficacy and Effectiveness of Azacitidine In Elderly Patients with Acute Myeloid Leukemia and Blasts Counts below 30%: Experience of the Spanish Registry

Analysis of Spanish Experience During Imiglucerase Shortage

A New Prognostic Scoring System Including Transfusion Dependency and Cytogenetic Abnormalities for Patients with Chronic Myelomonocytic Leukemia.

Chronic Myelomonocytic Leukemia (CMML) with More Than 15% of Ring Sideroblasts in Bone Marrow: An Overlapping Disorder Between CMML and Refractory Anemia with Ring Sideroblasts.

Treatment of Anemia with Darbepoetin Alfa in Patients with Low and Intermediate-1 Risk Myelodysplastic Syndromes. Results from the ARAMYS Study

Analysis of Cytogenetic Abnormalities and Their Prognostic Impact in a Series of 145 Mantle Cell Lymphoma Cases with An Abnormal Karyotype.

Prognostic Impact of Additional Chromosomal Aberrations (ACA) to 5q- in Patients with primary Myelodysplastic Syndrome.

Independent Impact of Iron Overload and Transfusion Dependency on Survival and Leukemic Evolution in Patients with Myelodysplastic Syndrome

ABL1 Gene Amplification and Aberration Involving HOX11L2/TLX3 in T-Acute Lymphoblastic Leukemia (T-ALL).

Elderly Patients with De Novo Acute Myeloid Leukemia (AML): Prognostic Factors in 132 Cases.

Acute Erythroid Leukemia (AEL): A Clinical, Morphological, Cytogenetic and Follow-Up Study of 69 Patients.

Additional Chromosome Abnormalities Have No Prognostic Value in Acute Promyelocytic Leukemia Patients Treated with Simultaneous ATRA and Anthracycline-Based Chemotherapy: An Update of the APL96 and APL99 Pethema Protocols.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only